- Home
- EDSA vs JNVR Comparison
EDSA vs JNVR Comparison
Compare EDSA & JNVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EDSA
- JNVR
- Stock Information
- Founded
- EDSA 2015
- JNVR 2018
- Country
- EDSA Canada
- JNVR United States
- Employees
- EDSA N/A
- JNVR N/A
- Industry
- EDSA Biotechnology: Pharmaceutical Preparations
- JNVR Finance: Consumer Services
- Sector
- EDSA Health Care
- JNVR Finance
- Exchange
- EDSA Nasdaq
- JNVR Nasdaq
- Market Cap
- EDSA 6.2M
- JNVR 5.4M
- IPO Year
- EDSA N/A
- JNVR 2023
- Fundamental
- Price
- EDSA $2.45
- JNVR $4.90
- Analyst Decision
- EDSA Strong Buy
- JNVR
- Analyst Count
- EDSA 1
- JNVR 0
- Target Price
- EDSA $21.00
- JNVR N/A
- AVG Volume (30 Days)
- EDSA 32.2K
- JNVR 17.2K
- Earning Date
- EDSA 05-09-2025
- JNVR 03-13-2025
- Dividend Yield
- EDSA N/A
- JNVR N/A
- EPS Growth
- EDSA N/A
- JNVR N/A
- EPS
- EDSA N/A
- JNVR N/A
- Revenue
- EDSA N/A
- JNVR $2,099,660.00
- Revenue This Year
- EDSA N/A
- JNVR N/A
- Revenue Next Year
- EDSA N/A
- JNVR N/A
- P/E Ratio
- EDSA N/A
- JNVR N/A
- Revenue Growth
- EDSA N/A
- JNVR 4.82
- 52 Week Low
- EDSA $1.55
- JNVR $3.37
- 52 Week High
- EDSA $5.59
- JNVR $10.64
- Technical
- Relative Strength Index (RSI)
- EDSA 53.34
- JNVR 53.17
- Support Level
- EDSA $2.31
- JNVR $4.45
- Resistance Level
- EDSA $2.55
- JNVR $6.46
- Average True Range (ATR)
- EDSA 0.12
- JNVR 0.79
- MACD
- EDSA -0.02
- JNVR 0.08
- Stochastic Oscillator
- EDSA 48.28
- JNVR 37.85
About EDSA Edesa Biotech Inc.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.
About JNVR Janover Inc.
Janover Inc is a B2B fintech marketplace providing a platform for commercial property borrowers and lenders. It provides a technology platform that connects commercial mortgage borrowers looking for debt to refinance, build, or buy commercial property including apartment buildings to commercial property lenders including banks, credit unions, REITs, debt funds, and more looking to deploy capital into commercial mortgages. The firm caters to two consumer segments: lenders and borrowers. It derives the majority of its revenue from transaction fees.